ARCHIVES

Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned

This article is from The Cancer Letter archive.

Vol. 13 No. 41 | October 23, 1987

Download PDF Visit The Full Archive

Related Articles

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013

Genetronics Phase II Trials For Head & Neck Completed.

May 4, 2001

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

NCI CTEP-Approved Trials For the Month of September

September 26, 2014

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

NCI Programs:Institute Informs Public About Thyroid Cancer Risk From Fallout.

January 3, 2003